MedTrace Logo

A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use Disorder

NCT05408247 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2023-03-16

No results posted yet for this study

Summary

To explore the effectiveness of n-acetylcysteine in improving treatment outcomes for alcohol use disorder in a double-blind randomised placebo-controlled trial.

Conditions

  • Alcohol Use Disorder (AUD)

Interventions

DRUG

N-acetyl cysteine

2400mg/day

DRUG

Placebo

Matched placebo

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-16
Primary Completion
2025-11-30
Completion
2026-11-30

Countries

  • Australia

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05408247 on ClinicalTrials.gov